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A new ﬂow procedure based on multicommutation with chemiluminometric detection was developed to quantify gentamicin
sulphateinpharmaceuticalformulations.Thisapproachisbasedongentamicin’sabilitytoinhibitthechemiluminometricreaction
between luminol and hypochlorite in alkaline medium, causing a decrease in the analytical signal. The inhibition of the analytical
signal is proportional to the concentration of gentamicin sulphate, within a linear range of 1 to 4μgmL −1 with a coeﬃcient
variation <3%. A sample throughput of 55 samples h−1 was obtained. The developed method is sensitive, simple, with low reagent
consumption, reproducible, and inexpensive, and when applied to the analysis of pharmaceutical formulations (eye drops and
injections) it gave results with RSD between 1.10 and 4.40%.
1.Introduction
Gentamicin is an aminoglycoside antibiotic with a wide
broad spectrum activity. It is produced by Micromonospora
purpurea and M. echinospora as a mixture of ﬁve major
related components designated as gentamicin C1, C1a, C2,
C2a,a n dC2b. These compounds are pseudotrisaccharides
containing a garasone and a purpurosamine glycosidically
linked to 2-deoxystreptamine, which diﬀers from each one
in their degree of methylation on the purpurosamine ring
[1–3].
Gentamicin has been quantiﬁed in diﬀerent matrices
such as biological samples [4–6], pharmaceutical formula-
tions [7–9], foodstuﬀs[ 10–12], and environmental samples
[13, 14]. Most of the proposed methods are based on
separation techniques [4–7, 11–14]w i t hd i ﬀerent detection
systems, conventional ﬂuorimetric methodologies [8, 9],
or immunoassays [10]. Due to lack of chromophores and
ﬂuorophores groups in its structure, it is diﬃcult to quantify
directly the gentamicin by using photometric or ﬂuorimetric
methods.Althoughtheproceduresareverysensitive,theyare
also expensive, because most of them rely on sophisticated
methods and are often diﬃcult to operate [4, 11, 12, 14]. In
addition, most of the time the sample needs to be prederiva-
tized, which is a time-consuming process and involves toxic
and environmentally unfriendly reagents [5, 6].
The oﬃcial methods for the assay of gentamicin sulphate
described in diﬀerent Pharmacopoeias are microbiological
for pharmaceutical preparations [15–17]a n df o rr a wm a t e -
rials is pointed out an HPLC method with UV detection for
identiﬁcation of the product [18]. The biological methods
[15–17] described for pharmaceutical preparations are time
consuming, of diﬃcult operation, and with low detectability
and precision as well as being subject to random error due
to the inherent variability of biological responses. For such
samples, in particular, other alternative methods have been
presented in literature. Most of them are based mainly on
chromatographic separation techniques with UV detection
[19,20],pulsedelectrochemicaldetection[21,22],andevap-
orative light-scattering detection (ELSD) [7, 23]. Fluorime-
try [8, 9], indirect spectrophotometry [24, 25], potentiome-
try [26], and amperometry [27] methods are also described.2 Journal of Automated Methods and Management in Chemistry
Chemiluminescence (CL) can be deﬁned as the pro-
duction of electromagnetic radiation (ultraviolet, visible,
or infrared) as a consequence of a chemical or biochem-
ical reaction. CL has become a powerful tool for drug
determination. It has wide-range applications, and low
detection limits can be measured with a simple, low-cost
instrument [28, 29]. The association of CL with techniques
based on continuous ﬂow systems has allowed to develop
highly sensitive analytical methods, which improves the
accuracy of measurements, increases the sample throughput,
and reduces considerably the reagent consumption and
consequently the production of waste when compared with
conventional procedures [30]. With continuous ﬂow systems
it is also possible to prepare online unstable reagents in a
more eﬃcient way [31]. In the literature two ﬂow-injection
analysis systems (FIA) applying sensitized chemilumines-
cence detection have been described for gentamicin [31, 32].
In the ﬁrst method, it is necessary to electrogenerate the
oxidant reagent (Co(III)) that is unstable [31], while in the
second method, gentamicin has to be previously derivatized
to be able to participate in the chemiluminometric reaction
[32].
Amongthevarioustechniquesofcontinuousﬂow,multi-
commutation ﬂow-injection analysis (MCFIA) is an alterna-
tive to increase versatility of ﬂow systems. The ﬂow system
manifold comprised a set of solenoid valves assembled to
work as independent commutation units, which controlled
by microcomputer allows facilities to insert sample and
reagent solutions following an intermittent pattern [33].
This process has the advantage of reducing both reagent
consumption and generation of waste. Sample and reagent
solutions can be handled using a single pumping channel,
thus simplifying the manifold [34].
In this paper, an analytical method for the determination
of gentamicin sulphate in pharmaceutical formulations
employing a multicommutated ﬂow system coupled with a
chemiluminometric detector was developed. The detection
process is based on a simple reaction, using common-
and low-toxic reagents. In this case, for the ﬁrst time,
the reaction between luminol and hypochlorite, in alkaline
medium,isusedtoquantifygentamicin,duetoitscapacityto
inhibit the analytical signal. The usefulness of the proposed
method was tested with commercial pharmaceutical formu-
lations.
2. Experimental
2.1. Chemicals. Gentamicin sulphate was purchased from
Sigma-Aldrich (St Louis, MO, USA); luminol, sodium
hypochlorite, and sodium carbonate decahydrate from
Fluka (Buchs, Switzerland); sodium hydrogen carbonate
and hydrochloric acid from Merck (Darmstadt, Germany);
sodium hydroxide from Riedel-de Ha¨ en (Seelze, Germany).
A l lr e a g e n t sw e r eo fa n a l y t i c a lg r a d ea n da l ls o l u t i o n sw e r e
prepared with Milli-Q water (conductivity <0.1μScm −1)
recently boiled.
The pharmaceutical formulations (eye drops and injec-
tions) were obtained in the local market.
2.2. Preparation of Solutions. A5 . 0× 10−3 molL−1 lumi-
nol stock solution was prepared by dissolving 22.2mg
of 5-amino-2,3-dihydro-1,4-phthalazinedione in 25mL of
0.1molL−1 sodium carbonate solution, with pH adjusted
to 9.2. A working solution of 2.0 × 10−4 molL−1 was daily
prepared by dilution of the stock solution in the same buﬀer.
A2 . 0× 10−5 molL−1 sodium hypochlorite solution was
also daily prepared by dilution in carbonate buﬀer pH 9.5
of a sodium hypochlorite solution obtained from Fluka.
Every week, the concentration of the commercial sodium
hypochlorite solution was checked. For that a 1% (v/v)
solution of sodium hypochlorite was prepared from the
commercial solution. The pH was adjusted to 6.2 with
diluted sulfuric acid, and the concentration was determined
spectrophotometrically by measuring its absorbance at 235
nm and applying a molar absorptivity of 100Lmol−1 cm−1
[35].
A 100μgmL −1 stock solution of gentamicin was daily
prepared by dissolving 5.0mg of gentamicin sulphate in
50mL ofwater.Working aqueousstandard solutions ranging
from 1 to 4μgmL −1 were prepared by dilution from the
latter.
2.3. Analysis of Commercial Pharmaceutical Formulations.
For eye drops formulations, a simple dilution with water was
performed prior analysis in order to get a ﬁnal gentamicin
concentration within the linear range of the method (1–
4μgmL −1).Asimilarapproachwasusedforinjectabledrugs.
However, because of the high content of sodium bisulphite
in their composition, added as preservative, it was necessary
to carry out a procedure adapted from Amorim et al.
[36]. A volume corresponding to 0.5mL of the injectable
drug was diluted in 14.5mL of water and acidiﬁed with
50μL of concentrated hydrochloric acid. Afterwards, the
solution was bubbled with nitrogen for 20 minutes to release
the dissolved sulfur dioxide and neutralized with sodium
hydroxide. Finally a dilution with water was carried out
in order to obtain a gentamicin content included in the
analytical range of the method.
2.4.Apparatus. Measurementswereperformedwithachem-
iluminescence detector comprising a Hamamatsu HS5784-
04 (Hertfordshire, UK) photosensor module assembled with
a spiral-shaped ﬂow cell (40μL internal volume) constructed
in Perspex, which was attached to the photosensor module
window [37]. The multicommutation ﬂow system depicted
in Figure 1(a) comprises three three-way solenoid valves
161 T031 (NResearch Inc., West Caldwell, USA) and a
Minipuls 3 peristaltic pump (Gilson, Viliers-le-Bell, France)
with PVC pumping tubes (i.d. = 0.76 and 1.3mm) as
the propulsion system. The diﬀerent components of the
multicommutated ﬂow system were connected with 0.8mm
i.d. PTFE tubing and a reaction coil of 50cm was made
withthesamePTFEtube.Homemadeconﬂuenceconnectors
were also used. Control of the analytical system, data
acquisition and processing were carried out by means of
a microcomputer coupled to a PC-LABCard model PCL-
711B Advantech (American Advantech Corp., San Jose, CA)Journal of Automated Methods and Management in Chemistry 3
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Figure 1: (a) scheme of the multicommutated ﬂow system
employed. S: sample; R1: hypochlorite solution (carrier solution);
R2: luminol solution; Pp: peristaltic pump; V1, V2,a n dV3: solenoid
valves; X and Y: conﬂuence points; RC: reaction coil; D: chemi-
luminometric detector; W: waste. (b) schematic representation of
solenoid valves actuation during each analytical cycle. V1, V2,a n d
V3: solenoid valves; ts: sampling time; td: insertion time of luminol,
reaction of this with the mixture sample/hypochlorite and signal
detection.
electronic interface card and running a software written in
QuickBasic Version 4.5.
Spectrophotometric measures for evaluating the concen-
tration of commercial sodium hypochlorite solution were
made by using a Perkin Elmer 45UV/Vis double beam
spectrophotometerandquartzcellswith1cmofopticalpath.
2.5. Flow Injection Protocol. Three three-way solenoid valves
(V1, V2,a n dV3) assessment to the system was enabled by the
sample and reagents: V1 for the sample (S), while V2 and V3
inserted the hypochlorite (R1) and luminol (R2) solutions,
respectively. The hypochlorite solution worked also as the
carrier solution.
The analytical cycle (Figure 1(b)) started with the binary
sampling of sample and hypochlorite solutions into the ana-
lytical path by the alternate actuation of solenoid valves V1
andV2,duringaﬁxedtimeinterval.Afterwards,valveV1 was
switched oﬀ, while valve V2 h a dr e m a i n e ds w i t c h e do n ,t h u s
hypochlorite ﬂowed continuously to displace the mixture
sample/hypochlorite towards the conﬂuence Y, where lumi-
nol solution was added through the solenoid valve V3.T h e
signal acquisition started with the introduction of luminol
solution and persisted for a pre-deﬁned period of time, after
the valve V3 has been switched OFF. Sample concentration
was evaluated by the decrease of the monitored analytical
signal, corresponding to the hypochlorite consumption by
gentamicin. In the proposed procedure, the analytical signal
related to the blank solution (reference signal) corresponded
to the maximum of chemiluminescence emission.
2.6. Experimental Procedures
2.6.1. Optimized Flow System and Chemical Conditions. The
quantiﬁcation of gentamicin was performed by using a 2.0 ×
10−4 molL−1 luminol solution with a pH of 9.2 and a 2.0 ×
10−5 molL−1 hypochloritesolutionwithapHof9.5,atroom
temperature. On each analysis were used 725μL and 41.7μL
ofsampleandluminolvolumes,respectively.Theﬂowrateof
sample and hypochlorite was 2.9mLmin−1 and the luminol
one was 1.15mLmin−1.
2.6.2. Calibration Curve Using Gentamicin Sulphate. As e r i e s
of working standards solutions of gentamicin sulphate,
prepared in water, in the range of 1 to 4μgmL −1,w e r e
measured in triplicate and the diﬀerence of signal relatively
to the blank was used to construct the corresponding
calibration curve.
2.6.3. Recovery Studies. R e c o v e r i e ss t u d i e sw e r em a d eb y
using the proposed method, after addition of 0.6–1.0mL of a
100μgmL −1 gentamicin sulphate solution to 100mL of sam-
ple solution, in order to achieve a gentamicin concentration
around of 2.0μgmL −1, which is in the linear range of the
developed method.
3. Results and Discussion
The proposed method is based on the ability of gen-
tamicin to inhibit the oxidation reaction between luminol
and hypochlorite in alkaline medium. This aminoglycoside
antibiotic has several amine groups prone to oxidation
by hypochlorite [38–41], resulting in an inhibition of the
analytical signal, which is proportional to the concentration
of gentamicin. Since the method is based on the chemilumi-
nometric signal inhibition, a maximization of the reference
signal is necessary in order to improve the analytical signal.
3.1.OptimisationofChemicalConditions. Inordertoachieve
the maximum of sensitivity of the reaction some chemical
variables were studied such as the inﬂuence of concentration
and pH of hypochlorite and luminol solutions involved in
the reaction by using a univariate approach. Hypochlorite
concentrations were investigated from 5.0 × 10−6 to 3.5
× 10−5 molL−1, and the results showed that inhibition of
chemiluminescence signal was higher for the concentration
of 2.0 × 10−5 molL−1. The inﬂuence of pH of hypochlorite
solution in the reaction was studied in the range from 9 to4 Journal of Automated Methods and Management in Chemistry
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Figure 2: Inﬂuence of hypochlorite’s pH in the analytical signal.
Dotted line: Reference signal; Continue line: Gentamicin standard
solution (1μgmL −1).
11 (Figure 2). The reference signal intensity was higher for
pH10,althoughtheinhibitioneﬀectofgentamicinwasmore
pronounced for pH 9.5. Hence this pH value was chosen for
further studies.
A similar study varying the concentration of luminol
solution between 5.0 × 10−5 and 4.0 × 10−4 molL−1 was
performed, and a higher decrease of the chemiluminescence
signal was observed for a luminol concentration of 2.0
× 10−4 molL−1. The inﬂuence of the pH in the luminol
reaction was investigated using buﬀer solutions in a pH
range from 8 to 12.6. The analytical signal increased with
the increase of the pH of luminol solution. However, at a pH
value of 9.5 occurred a saturation of the detector, whereby it
was decided to use a luminol solution with pH adjusted to
9.2, as a compromise between the analytical signal intensity,
the hypochlorite concentration previously selected, and the
detector saturation.
3.2. Optimisation of Flow System Conditions. To obtain a
good correlation between the inhibition of the analytical
signal and the concentration of gentamicin, ﬂow parameters
such as the time of reaction between hypochlorite and
gentamicin, the volume of sample inserted, and the ﬂow rate
were also studied.
The time of reaction between hypochlorite and gentam-
icin is important to obtain a maximum rate in the signal
inhibition. In order to achieve this purpose, reaction coils
with lengths of 12.8, 50, and 100cm were inserted between
the two conﬂuences X and Y as shown in Figure 1(a).T h e
results reveal that a higher inhibition of the analytical signal
was obtained for a reaction coil of 50cm.
The inﬂuence of the sample volume was also investigated
varying the time interval for its insertion between 9.0 to
30.0 seconds, corresponding to sample volumes from 435 to
1450μL, respectively. A higher inhibition of the analytical
signal was achieved for 725μL of sample solution, which
corresponds to 10 sampling cycles with a time interval of
1.5s.
The ﬂow rate is another critical parameter for the
chemiluminescencedetectionbecauseitdeﬁnestheresidence
time of the sample zone in the ﬂow cell. Flow rates between
2.1 and 3.5mLmin−1 for sample and hypochlorite solutions
as well as from 0.85 to 1.45mLmin−1 for luminol solution
Table 1: Comparision of diﬀerent chemiluminometric methodolo-
gies applied to ﬂow systems for determination of gentamicin in
pharmaceutical formulations.
Li et al. [31] Ramos-Fern´ andez
et al. [32]
Proposed
method
Sample volume
(μL)
100 1000 725
Gentamicin
prederivatization
No Yes (with OPA) No
Linear range
(μgmL −1)
0.01–80 3.93–30 1–4
Detection limit
(μgmL −1)
0.005 1.18 0.023
Sample
throughput
∼60 h−1 Not described 55 h−1
Intermediate
precision (%)
<3.2 Not described <3
OPA: o-phthalaldehyde.
were tested. It was noticed that the reference range of signal
intensity was higher when the ﬂow rate was 3.5mLmin−1
for the sample and hypochlorite solutions conjugated with
1.45mLmin−1 for luminol. However, the inhibition eﬀect
of gentamicin was more pronounced for a ﬂow rate of
2.9mLmin−1 (sample and hypochlorite solutions) and
1.15mLmin−1 (luminol solution). Therefore, these ﬂow
rates were chosen for the following studies.
3.3. Interferences. The interference of chemical compounds
such as arginine, sodium bisulphite, cetrimide, benzalko-
nium chloride, sodium chloride, potassium dihydrogen-
phosphate, EDTA, monosodium phosphate, disodium phos-
phate, glycerol, methylparaben, propylparaben, hydroxyl-
β-cyclodextrin, sodium mercuriothiolate, PVP, dexametha-
sone,indometacin,andtetryzoline,usuallyusedasexcipients
in pharmaceutical formulations (eye drops and injections),
was studied by using a 2.5 × 10−6 molL−1 of ﬁxed con-
centration of gentamicin. This solution was spiked with the
referred substances, at diﬀerent proportions. Proportions
of interfering/gentamicin of 100:1, 50:1, 25: 1, 10:1,
and 1:1 were tested. A chemical compound would be
considered to interfere if its presence resulted in a variation
of the analytical signal around 3% (±3%) relative to the
analytical signal obtained without excipient [37]. The results
showed a variation of analytical signal higher then 19%
for 1:1 proportion for arginine, sodium bisulphite, and
sodium mercuriothiolate species. Nevertheless, arginine and
sodium mercuriothiolate are presented in pharmaceutical
formulations but at very low concentrations when compared
with those tested. The probability of interfering with the
analytical determination is low, as evidenced by tests carried
out in Indobiotic eye drops formulation. However, for the
sodium bisulphite, there was a variation of the analytical
signal of around 20% even for the lowest proportions of
interfering. Therefore, in these cases, after acidiﬁcation,
samples were bubbled with a nitrogen stream. The nitrogen
bubbling time was evaluated for a period of time betweenJournal of Automated Methods and Management in Chemistry 5
Table 2: Determination of gentamicin sulphate in diﬀerent pharmaceutical formulations.
Pharmaceutical formulation Concentration
declared (mg mL−1)
Concentration
found (mg mL−1)a RSD (%)
Eye drops
Gentocil 4.42 4.41 ± 0.15 3.33
Ophtagram 3.00 2.99 ± 0.13 4.32
Indobiotic 5.08 5.13 ± 0.16 3.11
Dexamytrex Ophtiole 5.00 4.90 ± 0.05 1.10
Colircus´ ıG e n t a d e x a 4.42 4.44 ± 0.06 1.31
Injection
Garalone 80 81 ± 44 . 4 0
aEach determination corresponds to an average ± standard deviation of three analyses made with two samples from the same package.
10 and 30 minutes. It was observed that a time of 20 minutes
was enough to reduce the analytical signal to values near the
corresponding signal of gentamicin for the same proportion.
3.4. Figures of Merit for the Proposed Method. After opti-
misation of the ﬂow system relative to chemical and ﬂow
conditions, it was possible to achieve an analytical linear
rangebetween1and4μgmL −1 ofgentamicinandadetection
limit of 0.023μgmL −1. For a conﬁdence degree of 95%,
the calibration curve is expressed as ΔE = 210 (±7) C +6
(±16), ΔE being the variation of the analytical signal, in
arbitrary units, and C being the concentration of gentamicin
sulphate, in μgmL −1.Ac o e ﬃcient of variation between 0.58
and 2.34% (n = 10) was obtained, for the analysis of
standard solutions of gentamicin within the analytical linear
range of the proposed method. RSD values lower than 3%
were acquired for the intermediate precision. The proposed
method allowed a sample throughput of 55 samples h−1.
Table 1 comparestheresultsobtainedwiththosegivenby
other authors, for the assay of gentamicin in ﬂow conditions
[31, 32] proved that the limit of detection were of the same
orderofmagnitude.Theaccuracyoftheresultswas,however,
betterthanthosegivenin[31]andalsowasthesampling rate
[31, 32].
3.5. Analysis of Pharmaceutical Formulations. The proposed
method was applied to the determination of gentamicin
sulphate in commercial pharmaceutical formulations (eye
drops and injections) commercialized in Portugal. The
results obtained are summarized in Table 2 and are in good
agreement with the labelled content. In order to evaluate the
validity of the proposed method for the determination of
gentamicin in pharmaceutical formulations, recovery studies
were carried out on samples to which known amounts of
gentamicin were added. A mean of recovery value of about
99.5 ± 3.3% was obtained.
The oﬃcially accepted methods for the determination
of gentamicin in pharmaceutical preparations are based on
microbiological assays [15–17]. The biological variability
of results obtained does not allow to correlate with the
analytical results obtained by the proposed method. In
order to validate the analytical results, we tried to adapt
a method based on HPLC with UV detection, proposed
by the British Pharmacopeia and used for identiﬁcation
of raw materials [18]. In this, the proportion of main
components of gentamicin (gentamicin C1, C1a, C2,a n dC2a)
is assessed after its derivatization with o-phthalaldehyde and
mercaptoacetic acid. When trying to adapt this method to
the analysis of pharmaceutical products, the proportion of
the main components of gentamicin in the standards was
not equivalent to the real samples, so it was not possible to
correlate the total areas of peaks with the concentration of
gentamicin. This diﬀerence was observed for all the samples.
4. Conclusions
The described multicommutated ﬂow system with chemilu-
minometric detection allowed an exact and rapid quantiﬁca-
tion of gentamicin sulphate in pharmaceutical formulations
(eye drops and injections). Besides being economic, the
proposed ﬂow system has the advantage of producing a low
waste of residues when compared with other methods based
on ﬂow techniques, previously proposed [31, 32], being ver-
satile enough and easy to operate. The chemiluminescence
reactionproposedfordetectionusescommon-andlow-toxic
reagents, contrary to the methods proposed by other authors
[31, 32], which makes the method more environmentally
friendly.
This approach represents an advantageous alternative to
the oﬃcially accepted microbiological method, which can be
implemented in a simple manner in any laboratory quality
control in pharmaceutical industry.
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